Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion type Assertion NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_head.
- NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion description "[In breast tumors, overexpression was the main alteration observed for PKC?/? (33.4%), PKC? (29.5%) and PKC? (9.6%), whereas underexpression was the main alteration observed for PKC? (27.3%), PKC? (11.6%), PKC? (8.7%) and PKN2 (8.1%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_provenance.
- NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion evidence source_evidence_literature NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_provenance.
- NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion SIO_000772 22511072 NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_provenance.
- NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion wasDerivedFrom befree-20140225 NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_provenance.
- NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_assertion wasGeneratedBy ECO_0000203 NP926176.RA9l7V3a3Ayl6oAF_D5P2BIKBdZXDzLMiFOjmTE78DSx4130_provenance.